BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TetraLogic Pharmaceuticals 

365 Phoenixville Pike

Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-889-9900 Fax: 610-889-9994


SEARCH JOBS




Industry
Pharmaceutical

Segment
Start Up





 Company News
TetraLogic Pharmaceuticals (TLOG) Announces Results Of Preclinical Studies In Hepatitis B 11/10/2014 8:20:11 AM
TetraLogic Pharmaceuticals (TLOG) Announces Appointment Of Mary Ann Gray, Ph.D. And Mr. Michael D. Kishbauch As New Directors 11/7/2014 12:22:25 PM
TetraLogic Pharmaceuticals (TLOG) Reports Third Quarter Financial Results And Provides Clinical Programs Update 11/6/2014 10:47:42 AM
TetraLogic Pharmaceuticals (TLOG) To Host Investor Forum On November 10, 2014 11/3/2014 10:15:04 AM
TetraLogic Pharmaceuticals (TLOG) To Present Data From Pre-Clinical Studies With Hepatitis B At The 2014 International Meeting On Molecular Biology Of Hepatitis B Viruses 8/27/2014 7:49:15 AM
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014 8:56:19 AM
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014 8:49:26 AM
TetraLogic Pharmaceuticals (TLOG) Announces Conference Call With Dr. Marc Pellegrini Of The Walter and Eliza Hall Institute of Medical Research To Discuss Tetralogic Infectious Disease Program 6/13/2014 8:33:36 AM
TetraLogic Pharmaceuticals (TLOG) Announces Preclinical Data Indicating Birinapant's Breadth Of Activity In Models Of Infectious Disease 6/9/2014 9:20:24 AM
TetraLogic Pharmaceuticals (TLOG) To Present Data From Its Clinical Investigation Of SHAPE At The Annual American Society of Clinical Oncology Meeting 5/28/2014 9:55:14 AM
12345